Page last updated: 2024-08-20

potassium cyanide and scopolamine hydrobromide

potassium cyanide has been researched along with scopolamine hydrobromide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ano, M; Hirata, K; Kitamura, K; Maekawa, M; Narita, H; Ono, S; Ukai, W; Yamafuji, T1
Amano, M; Goto, A; Hasegawa, T; Nabeshima, T; Takahashi, N1
Aburada, M; Ikarashi, Y; Ikeya, Y; Karakida, F; Takeda, S; Tsunakawa, M; Yamaguchi, T1

Other Studies

3 other study(ies) available for potassium cyanide and scopolamine hydrobromide

ArticleYear
Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia.
    Japanese journal of pharmacology, 1993, Volume: 62, Issue:1

    Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Diethylamines; Energy Metabolism; Glycolysis; Hypoxia, Brain; Imipramine; Male; Mice; Mice, Inbred Strains; Pentobarbital; Potassium Cyanide; Scopolamine; Sleep; Tacrine; Thiophenes

1993
Effects of BMY-21502 on anoxia in mice.
    Japanese journal of pharmacology, 1993, Volume: 61, Issue:3

    Topics: Animals; Atmospheric Pressure; Benzoquinones; Brain Ischemia; Disease Models, Animal; Hypoxia, Brain; Male; Mice; Potassium Cyanide; Psychotropic Drugs; Pyrimidines; Pyrrolidines; Pyrrolidinones; Scopolamine; Ubiquinone

1993
Cerebral protective and cognition-improving effects of sinapic acid in rodents.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:3

    Topics: Acetylcholine; Amnesia; Animals; Carbon Dioxide; Cognition; Coma; Coumaric Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Frontal Lobe; Hypoxia; Ibotenic Acid; Male; Medicine, Kampo; Memory Disorders; Mice; Mice, Inbred ICR; Neuroprotective Agents; Parietal Lobe; Potassium Cyanide; Rats; Rats, Wistar; Scopolamine; Survival Rate

2007